Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 300
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data
Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast
BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
Mydecine Innovations Group Announces Filing of a Provisional Patent for Mindleap’s...
Field Trip Health Ltd. Reports Third Fiscal Quarter 2021 Financial Results
The Ultimate Guide to Pets and Psychedelics
Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Delineates Parameters...
Cambridge City Councilors Approve Psychedelics Decriminalization Measure
Tryp Therapeutics Launches Clinical Trials to Investigate Psilocybin for Over-Eating Disorders
Alberta’s First Full-Service Psychedelic Therapy Clinic Opens in Calgary, Ushering in...
Entheon Biomedical Hires Chief Business Officer; Senior Pharma Executive Dr. Brian...
PT231 – Dr. Hassan Tetteh – Human Care Over Health Care
MINDCURE’s Proprietary Bioinformatics Platform, PsyCollage, Beta Tested and Deployed for Product...
Load more